Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

What’s New in the Simcyp Simulator v17?

Watch this webinar with Nikunjkumar Patel, Oliver Hatley, and Matthew Harwood to learn how the latest updates in the Simcyp Simulator v17 will help provide insights that support developing safer, more effective medications.

Speaker(s): Nikunjkumar Patel, Matthew Harwood, Oliver Hatley
Solution: PBPK Modeling & Simulation
Therapeutic Area: Oncology/Hematology
More Info

Simcyp In Vitro Analysis (SIVA) Toolkit: Get the Most from Your In Vitro Data

Analysis of in vitro data from whole cell systems and dissolution studies is complex, challenging and time consuming. Yet accurate data analysis and informed data interpretation early in drug development is crucial. Existing tools have mainly been developed for broader data analysis and are not specifically designed for in vitro systems. These software tools do not readily support analysis […]

Speaker(s): Nikunjkumar Patel, Howard Burt
More Info

Annual Report—Simcyp Consortium Meeting

It may be 2016, but we just held the 17th annual Simcyp Consortium meeting in Sheffield, UK. This year’s gathering had >120 attendees with representatives from all but one of the 34 consortium member companies joining. The opening session reviewed the progress made by the Simcyp staff toward the field of regulatory science, physiologically-based pharmacokinetic […]

Solution: PBPK Modeling & Simulation
More Info

5 Updates to the Simcyp Simulator You’ll Be Psyched About

The Simcyp™ Population-based Simulator streamlines drug development through the modelling and simulation of physiologically-based pharmacokinetics (PK) and pharmacodynamics (PD) in virtual patient populations. It incorporates numerous databases containing human physiological, genetic and epidemiological information. By integrating this information with in vitro or clinical data, the Simulator can predict PK/PD behavior in ‘real-world’ populations. It can be used to select […]

Solution: PBPK Modeling & Simulation
More Info

Certara Announces Completion of Acquisition of Simcyp Limited

Acquisition of Simcyp adds important predictive science methodologies to Certara’s translational science approach to drug development. ST. LOUIS, MO –March 13, 2012 – Certara™, a Vector Capital portfolio company and a leading provider of drug discovery and development software and scientific consulting services, today announced the completion of its acquisition of UK-based Simcyp Limited.  Simcyp […]

Solution: PBPK Modeling & Simulation
More Info

Certara Announces Acquisition Agreement with Simcyp Limited

Acquisition will add powerful preclinical research capability to Certara’s translational science approach to drug development. ST. LOUIS, MO – February 24, 2012 – Certara™, a leading provider of drug discovery and development software and scientific consulting services and a Vector portfolio company, today announced agreement to acquire Simcyp Limited.  Simcyp is a UK-based, leading research company […]

Solution: PBPK Modeling & Simulation
More Info

Pharma Leaders in China Embrace Simcyp Science

Will the 21st century go down in history as the “Chinese Century”? If the status of its pharmaceutical industry is a barometer for China’s global position, then the answer may be “yes.” The size of the Chinese pharmaceutical market is second only to the US. In 2014, it was worth $105 billion. By 2020, the […]

Solution: PBPK Modeling & Simulation
More Info
Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog